Form 8-K - Current report:
SEC Accession No. 0001104659-25-033391
Filing Date
2025-04-09
Accepted
2025-04-09 16:05:24
Documents
16
Period of Report
2025-04-05
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2511732d1_8k.htm   iXBRL 8-K 27430
2 EXHIBIT 16.1 tm2511732d1_ex16-1.htm EX-16.1 3903
6 GRAPHIC tm2511732d1_8kimg001.jpg GRAPHIC 4795
7 GRAPHIC tm2511732d1_8kimg003.jpg GRAPHIC 5135
  Complete submission text file 0001104659-25-033391.txt   222682

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20250405.xsd EX-101.SCH 3026
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20250405_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20250405_pre.xml EX-101.PRE 22366
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2511732d1_8k_htm.xml XML 3812
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 25825222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)